[
    "ormations to be performed. The protection and deprotection conditions are well known to the skilled artisan. See. e.g., Greene and Wuts, Protective Groups in Organic Synthesis, (T. Greene and P. Wuts, eds., 2d ed. 1991).</p>PREPARATIONS AND EXAMPLESThe following Preparations and Examples further illustrate the invention and represent typical synthesis of the compound of the invention. The reagents and starting materials are readily available or may be readily synthesized by one of ordinary skill in the art. It should be understood that the Preparations and Examples are set forth by way of illustration and not limitation, and that various modifications may be made by one of ordinary skill in the art.</p>The R or S configuration of the compound of the invention may be determined by standard techniques such as X-ray analysis and correlation with chiral-HPLC retention time. The naming of the following Preparations and Example is generally performed using the IUPAC naming feature in MDL Accelrys\u00ae Draw version 4.0.NET.</p>As used herein, the following terms have the meanings indicated: \u201cACN\u201d refers to acetonitrile; \u201cBSA\u201d refers to bovine serum albumin; \u201cDCM\u201d refers to dichloromethane; \u201cDIPEA\u201d refers to N,N-diisopropylethylamine; \u201cDMF\u201d refers to dimethylformamide; \u201cDMSO\u201d refers to dimethylsulfoxide; \u201cEDTA\u201d refers to ethylenediaminetetraacetic acid; \u201cEtOAc\u201d refers to ethyl acetate; \u201cEtOH\u201d refers to ethanol; \u201cFBS\u201d refers to fetal bovine serum; \u201cHRP\u201d refers to horseradish peroxidase; \u201cIC50\u201d refers to the concentration of an agent which produces 50% of the maximal response; \u201cIPA\u201d refers to isopropyl alcohol; \u201cMeOH\u201d refers to methanol; \u201cMTBE\u201d refers to methyl tert-butyl ether; \u201cPBS\u201d refers to phosphate buffered saline; \u201cRT\u201d refers to room temperature; \u201cTEA\u201d refers to triethylamine; \u201cTFA\u201d refers to trifluoroacetic acid; \u201cT<sub>R</sub>\u201d refers to time of retention; \u201cTHF\u201d refers to tetrahydrofuran; and \u201cTMB\u201d refers to 3,3\u2032,5,5\u2032-tetramethylbenzidine.</p>LC-MS conditions (low pH): column: Phenomenex Gemini NX C18 2.1\u00d750 mm 3.0 m; gradient: 5-100% B in 3 min, then 100% B for 0.75 min column temperature: 50\u00b0 C.+/\u221210\u00b0 C.; flow rate: 1 mL/min; Solvent A: deionized water with 0.1% formic acid; Solvent B: ACN with 0.1% formic acid.</p>Preparation 16-Chloro-2-methylpyrimidin-4-amine<img id=\"EMI-C00007\" path=\"US09035051-20150519-C00007.TIF\" file=\"https://surechembl.org/api/assets/attachment/301028152/US/20150519/B1/000009/03/50/51/US09035051-20150519-C00007.TIF\"/></p>Charge a 5 L steel pressure vessel (autoclave) with 4,6-dichloro-2-methylpyrimidine (400 g, 2.45 mol) and ammonium hydroxide (2.8 L) at RT. Heat the reaction to 90\u00b0 C. for 5 h. Cool the reaction mixture to RT and then filter the solid through a Buchner funnel. Wash the filtercake with water (200 mL) and hexane (200 mL) and then dry under vacuum to afford the title compound as a white solid (290 g, 82%). LC-ES/MS m/z 144.0 (M+1).</p>Preparation 26-Chloro-5-iodo-2-methylpyrimidin-4-amine<img id=\"EMI-C00008\" pa"
]